The following is a summary of “Real-World Outcomes Of Non-Small Cell Lung Cancer Patients Harbouring Kras G12c And Kras G12d Mutations,” published in the March 2025 issue of Lung Cancer by Shahnam et al. KRAS G12D and G12C mutations exhibit distinct biological and clinical characteristics that influence treatment response in patients with metastatic non-small-cell lung […]
The post Distinct Clinical and Treatment Profiles of KRAS G12D and G12C in NSCLC first appeared on Physician’s Weekly.
